Goodpath

Goodpath

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://goodpath.com

Last Round

Series A

Sep 11, 2025

Total Funding Raised

$4M

Momentum Score

50 /100

Company Overview

Goodpath is a healthcare technology company that provides integrative, AI-powered care for chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical AI, Patient Engagement, Mental Health

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

virtual care platformchronic condition managementemployee health benefitintegrative caretelehealthmusculoskeletal careMSKweight managementvirtual physical therapyGLP-1 prescribinghealth coachingmental health benefitmedical weight lossvalue-based caremulti-condition platformEmployee Assistance ProgramEAPcorporate wellnessself-insured employersAI-driven healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Goodpath Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Goodpath Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ASep 11, 2025
SeedApr 25, 2020

Key People

Founding team and executive leadership

Bill Gianoukos

CEO CoFounder

Founding Team

Goodpath Investors

Notable investors and investment history

InvestorRounds
Global Founders CapitalSeries A, Seed
Blindspot VenturesSeries A, Seed
Indicator VenturesSeries A
Switch VenturesSeries A, Seed
MassMutual VenturesSeries A
Healthy VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 31, 2025

    Company doubled its annual recurring revenue in the past year.

  • Sep 11, 2025

    $18M round completed.

Goodpath Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Goodpath Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Goodpath's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range76
Year Founded2018
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.